ILANIT 2020


Novel SGCG mutation causing Limb Girdle Muscular Dystrophy in a Bedouin kindred Gombosh M1, Halperin D1, Yogev Y1, Birk OS1,2

Maya Gombosh 1 Daniel Halperin 1 Yuval Yogev 1 Ohad Birk 1,2
1Microbiology, Immunology, Genetics, Ben Gurion University, Israel
2Institute of Human Genetics, Soroka Medical Center, Israel

Consanguineous Bedouin kindred from the Negev region of Israel presented with a phenotype of proximal muscle weakness, affecting several generations in an apparent autosomal recessive mode of inheritance. Linkage analysis was performed using 750K SNP arrays, yielding a single disease-associated locus with a LOD score of 2.93. Whole-exome sequencing data of an affected individual were analyzed and filtered using our in-house databases along with open access databases. Variants within the locus were further analyzed using Sanger sequencing and restriction analysis. Of those variants, only a single homozygous c.703-1G>A splice-site mutation in SGCG showed full segregation within the family and was not found in 400 healthy Bedouin controls. In-silico analysis of the novel c.703-1G>A variant showed that it is likely to abolish a splice acceptor site in the final exon, yielding a truncated protein, or leading to nonsense mediated decay. Mutations in SGCG were previously described as causative for Duchene-like Limb Girdle Muscular Dystrophy (LGMD) type 2C. Our data suggest that the novel SGCG homozygous mutation is the cause for the dominantly inherited disease in this kindred.









Powered by Eventact EMS